What Pfizer / AstraZeneca rerally meant to the M&A landscape

Now watching

Next video starts in : 7 Play

What Pfizer / AstraZeneca rerally meant to the M&A landscape

What Pfizer / AstraZeneca rerally meant to the M&A landscape
Replay video
Up next

Exclusive look at the 2016 Ford GT

Unlock your personal NFL Now stream by signing in to NFL.com

What Pfizer / AstraZeneca rerally meant to the M&A landscape

by Breakout Videos 2:31 mins

What Pfizer / AstraZeneca rerally meant to the M&A landscape

by Breakout Videos 2:31 mins

As is true in business so it is in life: just because someone really, really wants to be with you doesn’t mean you can play hard to get forever. After six-months of courting AstraZeneca, Pfizer announced that it had pulled its $118 billion offer and had no plans to attempt a hostile acquisition.

More From

Finance

Investing

Midday Movers

  1. 17:35

    China weighs on U.S. stocks, Netflix DVD business still thriving

  2. 4:33

    Airline profits soar, aided by fees

  3. 2:54

    Netflix's DVD operation fuels company expansion

  4. 3:04

    US stocks slip in midday trade; Chinese market drops

  5. 5:23

    N.J. Transit Board Goes 12 Years Without Dissent as Trains Crawl

  6. 2:29

    U.S. watchdog questions Smirnoff maker Diageo's U.S. distribution